WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MELANOMA RESEARCH ALLIANCE FOUNDATION, founded in 2007, is a community nonprofit in the Diseases & Disorders sector that reported $9.3M in total revenue in fiscal year 2023. Revenue fell 20% from the prior year — a significant decline worth monitoring. Expenses of $10.3M exceeded revenue, resulting in a 11% operating deficit.
TO END SUFFERING AND DEATH DUE TO MELANOMA BY COLLABORATING WITH ALL STAKEHOLDERS TO ACCELERATE POWERFUL RESEARCH, ADVANCE CURES FOR ALL PATIENTS, AND PREVENT MORE MELANOMAS.
THE MELANOMA RESEARCH ALLIANCE FOUNDATION ("MRA") SUPPORTS AMBITIOUS AND INNOVATIVE PROJECTS, SELECTED THROUGH A PEER-REVIEW PANEL AND INITIATED BY INDIVIDUAL SCIENTISTS AND SCIENCE RESEARCH TEAMS...
THE MELANOMA RESEARCH ALLIANCE FOUNDATION ("MRA") SUPPORTS AMBITIOUS AND INNOVATIVE PROJECTS, SELECTED THROUGH A PEER-REVIEW PANEL AND INITIATED BY INDIVIDUAL SCIENTISTS AND SCIENCE RESEARCH TEAMS, TO PREVENT, DETECT AND TREAT MELANOMA. MRA CONVENES A WORLD CLASS, CROSS-DISCIPLINARY GROUP OF EXPERT RESEARCHERS POSSESSING CLINICAL AND SCIENTIFIC EXPERTISE TO DEVELOP A RESEARCH AGENDA THAT WILL PROVIDE INNOVATIVE SOLUTIONS TO CRITICAL RESEARCH ISSUES LEADING TO MORE EFFECTIVE PREVENTION, EARLIER DETECTION AND BETTER TREATMENTS FOR MELANOMA. MRA MAKES GRANTS TO DOMESTIC AND FOREIGN RESEARCH UNIVERSITIES, MEDICAL SCHOOLS, AND NONPROFIT MEDICAL RESEARCH ORGANIZATIONS DIRECTLY INVOLVED IN DETERMINING THE CAUSES AND CURES OF MELANOMA ON THE CONDITION THAT SUCH RESEARCH BE MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY.
THE MRA OPERATES A PATIENT ENGAGEMENT PROGRAM THAT SUPPORTS INCREASED AWARENESS OF MELANOMA IN GENERAL, AND OF PREVENTION, DETECTION AND TREATMENT OPTIONS SPECIFICALLY. THE PATIENT ENGAGEMENT PROGRAM...
THE MRA OPERATES A PATIENT ENGAGEMENT PROGRAM THAT SUPPORTS INCREASED AWARENESS OF MELANOMA IN GENERAL, AND OF PREVENTION, DETECTION AND TREATMENT OPTIONS SPECIFICALLY. THE PATIENT ENGAGEMENT PROGRAM ALSO PROVIDES EDUCATION ABOUT AND PROMOTION OF CLINICAL TRIALS. THE PATIENT ENGAGEMENT PROGRAM INCLUDES DEVELOPMENT AND DISTRIBUTION OF EDUCATIONAL MATERIALS, THE PROVISION OF EDUCATIONAL FORUMS, A CLINICAL TRIAL NAVIGATOR FOR PATIENTS AND AN ON-LINE PATIENT COMMUNITY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $9,291,698 | $11,614,639 | -0.2% |
| Expenses | $10,316,517 | $15,668,313 | -0.3% |
| Net Income | $-1,024,819 | $-4,053,674 | -0.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MICHAEL KLOWDEN | DIRECTOR | 0.30 |
Director
|
$0 | $56,759 | $478,149 |
| JOHN HUNTER | TREASURER | 1.00 |
Officer
|
$0 | $73,124 | $563,431 |
| MARC HURLBERT | CHIEF EXECUTIVE OFFICER | 50.00 |
Officer
|
$378,659 | $35,440 | $414,099 |
| STEPHANIE KAUFFMAN | PRESIDENT & COO | 50.00 |
Officer
|
$300,852 | $66,328 | $367,180 |
| JOAN LEVY | CHIEF SCIENCE OFFICER | 40.00 |
Key Emp
|
$198,854 | $28,311 | $227,165 |
| TANISHA JACKSON | SCIENTIFIC PROGRAM DIRECTOR | 40.00 |
Highest
|
$155,659 | $26,246 | $181,905 |
| CODY BARNETT | SENIOR DIRECTOR COMMUNICATIONS | 40.00 |
Highest
|
$134,825 | $12,963 | $147,788 |
| JANINE RAUSCHER | DIR. OF DEVELOPMENT OPERATIONS | 40.00 |
Highest
|
$103,698 | $5,491 | $109,189 |
| DEBRA BLACK | CHAIR/CO-FOUNDER | 10.00 |
Officer
Director
|
$0 | $0 | $0 |
| EVAN BAYH | DIRECTOR/SECRETARY | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| LEON BLACK | DIRECTOR/CO-FOUNDER | 0.30 |
Director
|
$0 | $0 | $0 |
| LEE ALPERT | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| MARIA BELL | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| BEN BLACK | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| BARRY COHEN | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| ELLEN DAVIS | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| AMANDA EILIAN | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| JASON FEDERICI | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| JAMI GERTZ | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| DAISY HELMAN | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| SUSAN HESS | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| DENISE KELLEN | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| NANCY MARKS | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| MICHAEL MILKEN | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| RICHARD RESSLER | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| MARY JO ROGERS | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| JEFFREY ROWBOTTOM | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| IAN SCHUMAN | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| JONATHAN SIMONS | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| JONATHAN SOKOLOFF | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| ELIZABETH STANTON | DIRECTOR | 0.30 |
Director
|
$0 | $0 | $0 |
| SUZANNE TOPALIAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $9,291,698 | $10,316,517 | $24,538,655 | $-1,024,819 |
| 2022 | $11,614,639 | $15,668,313 | $27,333,346 | $-4,053,674 |
| 2021 | $7,467,315 | $11,287,116 | $32,267,462 | $-3,819,801 |
| 2020 | $8,116,130 | $15,513,267 | $37,054,829 | $-7,397,137 |
| 2019 | $22,512,773 | $13,031,027 | $43,192,719 | $9,481,746 |
| 2018 | $5,844,183 | $16,623,854 | $37,272,765 | $-10,779,671 |
Compare MELANOMA RESEARCH ALLIANCE FOUNDATION with other nonprofits in District of Columbia and across the country.